PETALING JAYA: A new affordable hepatitis C treatment will soon be introduced in Malaysia, making it possible for patients to receive treatment for the potentially fatal disease.
Malaysian pharmaceutical company Pharmaniaga Logistics Sdn Bhd (Pharmaniaga) had on Monday signed an agreement with Egyptian pharmaceutical company Pharco Pharmaceuticals (Pharco) and non-profit organization Drugs for Neglected Diseases initiative (DNDi) to supply a new hepatitis C treatment regimen that will be sold for about US$300 (RM1,256.83).
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
